Vickerman Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vickerman Investment Advisors's PFE Position: Q4 2025 in Review
Vickerman Investment Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 13,575 shares — an estimated $346K sold.
Vickerman Investment Advisors first reported a position in PFE in Q3 2021 and held it in 17 quarters. The position peaked at $3.09M in Q4 2022. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Vickerman Investment Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Vickerman Investment Advisors sold 13,575 Pfizer shares in Q4 2025, an estimated $346K.
- Vickerman Investment Advisors first reported a position in Pfizer in Q3 2021 and held it in 17 quarters.
- Vickerman Investment Advisors's Pfizer position peaked at $3.09M in Q4 2022.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Vickerman Investment Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.